|
Market Closed -
London S.E.
11:35:03 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 0.8000 GBX | -3.03% |
|
-5.88% | -27.27% |
| 10-14 | CelLBxHealth expands services deal with US pharmaceutical firm | AN |
| 10-14 | Cellbxhealth Expands Parsortix Platform Partnership with Pharmaceutical Company in US | MT |
Company Valuation: CelLBxHealth plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 279.7 | 131.5 | 30.6 | 33.06 | 12.5 | 9.091 | - | - |
| Change | - | -52.97% | -76.73% | 8.02% | -62.19% | -27.27% | - | - |
| Enterprise Value (EV) 1 | 247.8 | 99.64 | 14.39 | 22.63 | 5.151 | 7.491 | 10.49 | 10.89 |
| Change | - | -59.8% | -85.56% | 57.32% | -77.24% | 45.42% | 40.05% | 3.81% |
| P/E | -17.8x | -5.75x | -1.52x | -2.13x | -0.2x | -0.34x | -8.89x | -5x |
| PBR | 6.93x | - | 1.33x | 1.79x | - | 133x | -2.68x | - |
| PEG | - | -0.2x | 0.1x | 0.1x | -0x | 0x | 0.1x | -0.1x |
| Capitalization / Revenue | 276x | 126x | 14x | 11.6x | 9.25x | 0.6x | 0.34x | 1.1x |
| EV / Revenue | 245x | 95.7x | 6.58x | 7.91x | 3.81x | 0.5x | 0.39x | 1.31x |
| EV / EBITDA | -15.7x | -4.66x | -0.74x | -1.69x | -0.5x | -1.48x | -4.14x | - |
| EV / EBIT | -14.4x | -4.12x | -0.66x | -1.5x | -0.36x | -1.11x | -9.02x | -13.6x |
| EV / FCF | -15.7x | - | -0.95x | -1.63x | -0.54x | -1.33x | -3.53x | -21.8x |
| FCF Yield | -6.37% | - | -105% | -61.4% | -184% | -75% | -28.3% | -4.59% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.0667 | -0.0879 | -0.0773 | -0.0482 | -0.0551 | -0.0233 | -0.0009 | -0.0016 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1.013 | 1.041 | 2.186 | 2.862 | 1.351 | 15.13 | 27.03 | 8.3 |
| EBITDA 1 | -15.75 | -21.37 | -19.45 | -13.4 | -10.38 | -5.072 | -2.532 | - |
| EBIT 1 | -17.24 | -24.21 | -21.76 | -15.1 | -14.25 | -6.732 | -1.163 | -0.8 |
| Net income 1 | -15.01 | -21.69 | -20.13 | -14.26 | -19.51 | -8.55 | -1.85 | -1.8 |
| Net Debt 1 | -31.84 | -31.9 | -16.22 | -10.42 | -7.349 | -1.6 | 1.4 | 1.8 |
| Reference price 2 | 1.190000 | 0.505000 | 0.117500 | 0.102500 | 0.011000 | 0.008000 | 0.008000 | 0.008000 |
| Nbr of stocks (in thousands) | 235,030 | 260,467 | 260,467 | 322,528 | 1,136,403 | 1,136,403 | - | - |
| Announcement Date | 4/28/22 | 4/21/23 | 6/5/24 | 5/28/25 | 6/19/26 | - | - | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.34x | 0.5x | -1.48x | - | 12.13M | |
| 34.27x | 5.99x | 22.93x | 0.27% | 255B | |
| 38.97x | 6.89x | 21.81x | 0.63% | 161B | |
| 45.34x | 12.27x | 27.06x | -.--% | 151B | |
| 16.68x | 3.34x | 10.9x | -.--% | 64.33B | |
| 20.33x | 2.44x | 12.33x | 2.49% | 51.9B | |
| 47.52x | 11.7x | 25.8x | -.--% | 50.25B | |
| 34.83x | 6.84x | 21.72x | -.--% | 49.92B | |
| 33.7x | 6.66x | 22.63x | 0.59% | 48.77B | |
| 76.49x | 7.3x | 22.21x | -.--% | 42.93B | |
| Average | 34.78x | 6.39x | 18.59x | 0.44% | 87.5B | |
| Weighted average by Cap. | 37.75x | 7.31x | 21.97x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CLBX Stock
- Valuation CelLBxHealth plc
Select your edition
All financial news and data tailored to specific country editions
